Resources

Increased Viral Vector Yield: Development and Scale-Up Validation of Small Molecule Enhancers
April 20th, 2025PosterCell & Gene Therapies, Vaccines
The Impacts of Suppressing Cellular Innate Immune Responses on AAV Yields During Production
April 20th, 2025PosterCell & Gene Therapies
Increase Viral Vector Yield: Small Molecule Enhancers Validation at Multiple Scales
April 20th, 2025PosterCell & Gene Therapies
A Novel Approach to Enhancing Viral Vector Manufacturing Using Small Molecules
April 20th, 2025PosterCell & Gene Therapies
Bioprocess Modelling of Upstream Viral Vector Production
April 20th, 2025PosterCell & Gene Therapies
Development and Scale Up Validation of Small Molecule Viral Sensitizers for Increased Vaccine Manufacturing Yields
April 20th, 2025PosterVaccines
Increasing Vaccine Production Yields Using Small Molecules
April 20th, 2025PosterVaccines
Modeling Benefits of Viral Sensitizers to Increase Virus Production
April 20th, 2025PosterVaccines
Vaccine Vector Production Enhancement Using Small Molecule VSE™
September 3rd, 2024PosterCell & Gene Therapies

Virica uses cookies to provide a better website experience of our website. I agree to the Privacy Policy and Terms of Use. OK